Mesoblast Ltd Files 6-K Report
Ticker: MEOBF · Form: 6-K · Filed: Mar 12, 2024 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Mar 12, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
Mesoblast Ltd filed a 6-K on 3/11/24, check the ASX announcement for details.
AI Summary
On March 11, 2024, Mesoblast Limited filed a new release announcement with the Australian Securities Exchange. This filing is a Form 6-K report for the month of March 2024, indicating its status as a foreign private issuer. The company is incorporated in Australia and its principal executive offices are located in Melbourne.
Why It Matters
This filing provides an update on Mesoblast Limited's regulatory and corporate activities as a foreign private issuer. Investors should review the attached announcement for specific details.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- Australian Securities Exchange (company) — Filing recipient
- March 11, 2024 (date) — Filing date
FAQ
What type of filing is this?
This is a Form 6-K report, which is a report of a foreign private issuer.
When was this filing made?
The filing was made on March 12, 2024, and pertains to information as of March 11, 2024.
Who is the filer?
The filer is Mesoblast Limited.
Where is Mesoblast Limited incorporated?
Mesoblast Limited is incorporated in Australia.
What is attached to this Form 6-K?
A new release announcement filed by Mesoblast Limited with the Australian Securities Exchange on March 11, 2024, is attached as Exhibit 99.1.
Filing Stats: 213 words · 1 min read · ~1 pages · Grade level 16.9 · Accepted 2024-03-11 18:50:04
Filing Documents
- a2024-03x13fdasupportsacce.htm (6-K) — 20KB
- exhibit991.htm (EX-99.1) — 14KB
- exhibit991001.jpg (GRAPHIC) — 266KB
- exhibit991002.jpg (GRAPHIC) — 286KB
- exhibit991003.jpg (GRAPHIC) — 296KB
- 0001345099-24-000026.txt ( ) — 1203KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Paul Hughes Paul Hughes Company Secretary Dated March 13, 2024 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated March 11, 2024 .